Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
Allurion Technologies, Inc. (NYSE: ALUR) (Allurion or the Company), a pioneer in metabolically healthy weight loss, today announced it has passed critical milestones in the U.S. Food and Drug...